selected publications
- Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study. Annals of the rheumatic diseases. 2026 Academic Article GET IT
- Pre-treatment naïve T cells are associated with severe irAE following PD-1/CTLA4 checkpoint blockade for melanoma. JCI insight. 2025 Academic Article GET IT
- Arthroplasty Joint Histology and Surgical Outcomes in Patients on Immune Checkpoint Inhibitors: A Single-Center Case Series. The Journal of rheumatology. 2025 Letter GET IT
- Pre-treatment naïve T cells are associated with severe irAE following PD-1/CTLA4 checkpoint blockade for melanoma. 2025 GET IT
- Use of Apremilast for the Treatment of Immune Checkpoint Inhibitor Psoriasis and Psoriatic Arthritis. Arthritis care & research. 2025 Academic Article GET IT
-
Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study.
Rheumatology (Oxford, England).
2025
Academic Article
GET IT
Times cited: 9 - Prioritising domains of glucocorticoid therapy to measure in trials: Results from a modified delphi exercise from the OMERACT glucocorticoid impact working group. Seminars in arthritis and rheumatism. 2024 Academic Article GET IT
- Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows. Seminars in arthritis and rheumatism. 2024 Academic Article GET IT
-
Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis.
RMD open.
2023
Academic Article
GET IT
Times cited: 4 -
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Annals of the rheumatic diseases.
2023
Academic Article
GET IT
Times cited: 68 - Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment-specific patient-reported outcome measure. Rheumatology (Oxford, England). 2023 Academic Article GET IT
-
Rheumatic Complications of Immune Checkpoint Inhibitors.
Rheumatic diseases clinics of North America.
2022
Review
GET IT
Times cited: 4 - Checkpoint Inhibitor-Associated Autoimmunity: What a Rheumatologist Needs to Know. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2022 Academic Article GET IT
-
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition.
Journal for immunotherapy of cancer.
2022
Academic Article
GET IT
Times cited: 55 -
Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series.
2021
GET IT
Times cited: 58 - Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set. Seminars in arthritis and rheumatism. 2021 Academic Article GET IT
-
Rheumatic Complications of Immune Checkpoint Inhibitors.
The Medical clinics of North America.
2021
Review
GET IT
Times cited: 5 -
Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry.
ACR open rheumatology.
2020
Academic Article
GET IT
Times cited: 19 -
Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.
Journal for immunotherapy of cancer.
2020
Academic Article
GET IT
Times cited: 4 - Recurrent Complement-Mediated Thrombotic Microangiopathy in a Patient with Systemic Lupus Erythematosus: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2020 Academic Article GET IT
-
Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance.
Arthritis research & therapy.
2017
Information Resource
GET IT
Times cited: 23 -
Moving beyond the limitations of the visual analog scale for measuring pain: novel use of the general labeled magnitude scale in a clinical setting.
American journal of physical medicine & rehabilitation.
2014
Academic Article
GET IT
Times cited: 16 - A Review of Spasticity Treatments: Pharmacological and Interventional Approaches. Critical reviews in physical and rehabilitation medicine. 2013 Academic Article GET IT